Previous 10 | Next 10 |
Inhibrx ( NASDAQ: INBX ) on Monday said the European Commission had granted an orphan drug designation to the biotech's antibody INBRX-109 for the treatment of chondrosarcoma, a type of bonce cancer. The European Commission's approval was based on a positive recommendation...
European Medicines Agency Grants Orphan Drug Designation to INBRX-109 for the Treatment of Chondrosarcoma PR Newswire SAN DIEGO , Aug. 15, 2022 /PRNewswire/ -- Inhibrx, Inc. (Nasdaq: INBX), a biotechnology company with four clinical programs in developmen...
Over the past few days, there have been some monster moves across a number of Russell 3,000 stocks. Taking a look at the Russell 3,000 members that had at least been cut in half from the time of the index’s high on January 3rd through the low on June 16th, followed by a rally o...
Inhibrx press release ( NASDAQ: INBX ): Q2 GAAP EPS of -$0.97 misses by $0.19 . Revenue of $0.71M (-25.3% Y/Y) misses by $0.36M . For further details see: Inhibrx GAAP EPS of -$0.97 misses by $0.19, revenue of $0.71M misses by $0.36M
Inhibrx Reports Second Quarter 2022 Financial Results and Recent Corporate Highlights PR Newswire SAN DIEGO , Aug. 8, 2022 /PRNewswire/ -- Inhibrx, Inc. (Nasdaq: INBX), a biotechnology company with four clinical programs in development and a strong emergi...
Gainers: Greenwich LifeSciences ( GLSI ) +41% . Histogen ( HSTO ) +37% . Oramed Pharmaceuticals ( ORMP ) +25% . InMode ( INMD ) +13% . Annexon ( ANNX ) +11% . Losers: Can-Fite BioPharma ( CANF ) -11% . Arc...
Gainers: Inhibrx ( INBX ) +5% . Maxeon Solar Technologies ( MAXN ) +4% . Applied Molecular Transport ( AMTI ) +4% . Enovix Corporation ( ENVX ) +3% . Malibu Boats ( MBUU ) +3% . Losers: Kornit Digital ( KRNT ) -21% ...
Inhibrx Announces Completion of Phase 1 Combination Dose Escalation for INBRX-105, a Novel Targeted 4-1BB Agonist, and Draws an Additional $60 Million from Oxford Finance PR Newswire SAN DIEGO , June 30, 2022 /PRNewswire/ -- Inhibrx, Inc. (Nasdaq: INBX), ...
Positive results have been released thus far from a phase 1 study using INBRX-101 for the treatment of patients with Alpha-1 Antitrypsin Deficiency. It is expected that the Alpha-1 Antitrypsin Deficiency Augmentation therapy market could reach $1.95 billion by 2026. If FDA gives g...
Halvorsen's 13F portfolio value decreased from $34.49B to $24.74B this quarter. The number of positions decreased from 107 to 56. Viking Global increased Amazon.com, Fortive, and International Flavors & Fragrances while dropping Humana, Coupa Software, and Twilio. The top thre...
News, Short Squeeze, Breakout and More Instantly...
Inhibrx Inc. Company Name:
INBX Stock Symbol:
NASDAQ Market:
2024-07-23 06:30:08 ET JMP Securities analyst issues MARKET PERFORM recommendation for INBX on July 23, 2024 04:40AM ET. The previous analyst recommendation was Outperform. INBX was trading at $13.49 at issue of the analyst recommendation. The overall analyst consensus :...
A look at the top 10 most actives in the United States Maxeon Solar Technologies Ltd. (MAXN) rose 3.6% to $0.2493 on volume of 118,503,418 shares Qualigen Therapeutics Inc. (QLGN) rose 94.8% to $0.4 on volume of 100,863,101 shares AgriFORCE Growing Systems Ltd. (AGRI) rose 20.0% to $0.098...
Smart Share Global Limited (EM) is expected to report for Q1 2024 American Rebel Holdings Inc. (AREB) is expected to report for Q1 2024 First Republic Bank (San Francisco, California) (FRCB) is expected to report for Q1 2024 Spark Networks SE (LOVLQ) is expected to report for Q1 2024 ...